PR. J. Silvio Gutkind
PhD, Distinguished Professor of Pharmacology School of Medecine and Associate Director of Basic Science, Co-Director of the Head and Neck Cancer Center Moores Cancer Center, University of California San Diego.
His research team studies the molecular basis of cancer and more particularly the role of G proteins, GPCR and chemokine networks in cancer initiation, metastasis, and immune evasion. His translational efforts are aimed at targeting GPCRs and their signaling circuits in the new era of precision oncology and cancer immunotherapies. Dr. Gutkind is a graduate of the University of Buenos Aires, Argentina. He was a Branch Chief at the NIH from 1998 until 2015. He has been a member of many editorial boards of scientific journals as well as national and international advisory committees. He has published more than 400 studies in prestigious journals and organized multiple international symposia and meetings. As recent as October 2019, he was elected to become a member of the National Academy of Medicine, reflecting his team’s efforts in the area of cancer signaling and translational programs to prevent and treat human malignancies.